Clinical trial
Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
NCT00125008 · International Vaccine Institute, Other · Completed
Key facts
| NCT number | NCT00125008 |
|---|---|
| Title | Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever |
| Official title | Randomized Controlled Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever in Eastern Kolkata, West Bengal, India |
| Lead sponsor | International Vaccine Institute, Other |
| Collaborators | National Institute of Cholera and Enteric Diseases, India Wellcome Trust University of Western Ontario, Canada GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Typhoid, Paratyphoid Fever |
| Intervention type | Biological |
| Interventions | Typhoid Vi vaccine, Hepatitis A vaccine |
| Enrollment | 37,673 |
| Start date | May 1, 2003 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Jul 29, 2005 |
| Last update posted | Aug 26, 2008 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: